Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 0.7275 EUR -1.09%
Market Cap: 493.5m EUR
Have any thoughts about
Pharming Group NV?
Write Note

Pharming Group NV
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharming Group NV
Long-Term Investments Peer Comparison

Comparables:
PRQR
QURE
ARGX
MRUS
LVTX

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Pharming Group NV
AEX:PHARM
Long-Term Investments
$7.2m
CAGR 3-Years
-6%
CAGR 5-Years
5%
CAGR 10-Years
N/A
ProQR Therapeutics NV
NASDAQ:PRQR
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Long-Term Investments
$28.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
argenx SE
XBRU:ARGX
Long-Term Investments
$38.6m
CAGR 3-Years
-31%
CAGR 5-Years
92%
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Long-Term Investments
$150.6m
CAGR 3-Years
86%
CAGR 5-Years
67%
CAGR 10-Years
N/A
LAVA Therapeutics NV
NASDAQ:LVTX
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharming Group NV's Long-Term Investments?
Long-Term Investments
7.2m USD

Based on the financial report for Sep 30, 2024, Pharming Group NV's Long-Term Investments amounts to 7.2m USD.

What is Pharming Group NV's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
5%

Over the last year, the Long-Term Investments growth was -22%. The average annual Long-Term Investments growth rates for Pharming Group NV have been -6% over the past three years , 5% over the past five years .

Back to Top